Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Program crawled date : 2022 - 12 - 12 save search
Raytheon Technologies Board of Directors Authorizes $6 Billion Share Repurchase Program
Published: 2022-12-12 (Crawled : 22:00) - prnewswire.com
RTX | $100.75 -0.09% -0.1% 5.4M
|
Electronic Technology
|
| O: 2.02%
H: 0.38%
C: -1.65%
repurchase program
Ferrari N.v.: Periodic Report on the Buyback Program
Published: 2022-12-12 (Crawled : 20:00) - globenewswire.com
RACE | News | $416.0 1.13% 0.0% 260K
|
Consumer Durables
|
| O: 3.01%
H: 0.42%
C: -1.63%
report program
Washington Trust Bancorp, Inc. Announces 2023 Stock Repurchase Program
Published: 2022-12-12 (Crawled : 19:00) - prnewswire.com
WASH | $24.23 -0.29% -0.29% 68K
|
Finance
|
| O: 0.51%
H: 2.45%
C: -1.27%
repurchase program trust
Stellantis Partners With DTE Energy to Add 400 Megawatts of New Solar Projects in Michigan Through DTE's MIGreenPower Program
Published: 2022-12-12 (Crawled : 17:00) - prnewswire.com
STLA | News | $25.79 -0.04% 0.74% 3.5M
|
Manufacturing
|
| O: 0.48%
H: 0.69%
C: 0.48%
solar energy program
PBF Energy Announces $500 Million Share Repurchase Program
Published: 2022-12-12 (Crawled : 17:00) - prnewswire.com
PBF | $57.27 -0.61% -1.0% 1.3M
|
Energy Minerals
|
| O: 0.55%
H: 10.91%
C: 9.32%
energy repurchase program
ASML reports transactions under its current share buyback program
Published: 2022-12-12 (Crawled : 13:20) - globenewswire.com
ASML | News | $906.8 -7.18% -7.73% 3.7M
|
Producer Manufacturing
|
| O: -0.14%
H: 2.2%
C: 2.2%
program
GOGL - Transactions made under the buy-back program
Published: 2022-12-12 (Crawled : 08:00) - globenewswire.com
GOGL | $13.105 0.35% 0.34% 1.1M
|
Transportation
|
| O: 1.07%
H: 2.23%
C: 2.23%
program
CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition
Published: 2022-12-11 (Crawled : 00:00) - prnewswire.com
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: -2.22%
H: 6.26%
C: 5.99%
biopharma meeting program anemia
Genmab Showcases Data From Robust Development Program Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients Across a Broad Range of B-Cell Lymphomas at the 64th Annual ASH Meeting
Published: 2022-12-11 (Crawled : 00:00) - globenewswire.com
GNMSF | $285.11 3.83% 420
|
Health Technology
|
| O: 1.4%
H: 2.59%
C: -1.22%
GMAB | $28.51 -3.13% -3.23% 360K
|
Health Technology
|
| O: 0.09%
H: 3.47%
C: 2.83%
cd20 duobody lymphomas meeting program
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.